CA9 and renal carcinoma: In order to improve the efficacy of CAR-T and oncolytic adenovirus in tumor immunosuppressive microenvironment, here we used an oncolytic adenovirus arming decorin (OAV-Decorin) in combination with CAIX-targeting CAR-T for renal cancer cells.